Association of Cytomegalovirus (CMV) DNAemia With Long-Term Mortality in a Randomized Trial of Preemptive Therapy and Antiviral Prophylaxis for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative Liver Transplant...
Overview
Authors
Affiliations
In a post-hoc analysis of the association of CMV DNAemia with long-term mortality in a randomized trial of CMV preemptive therapy vs. antiviral prophylaxis in D+R- liver transplant recipients, post-intervention CMV DNAemia was associated with increased mortality after adjusting for study arm.
Antiviral Stewardship in Transplantation.
Bonda S, Trinh S, Hand J Viruses. 2025; 16(12.
PMID: 39772192 PMC: 11680139. DOI: 10.3390/v16121884.
Fang C, Dong C, Huang K, Wen N, Chen Y, Tang S Front Pharmacol. 2024; 15:1473891.
PMID: 39640481 PMC: 11617205. DOI: 10.3389/fphar.2024.1473891.
Reiss-Gindi N, Hoffman T, Ruderman T, Atamna A, Margalit I, Yahav D Infection. 2024; .
PMID: 39576569 DOI: 10.1007/s15010-024-02441-4.
Arvanitis P, Davis M, Farmakiotis D Transplant Rev (Orlando). 2024; 38(4):100860.
PMID: 38815340 PMC: 11586461. DOI: 10.1016/j.trre.2024.100860.
Recent advances in cytomegalovirus infection management in solid organ transplant recipients.
Grossi P, Peghin M Curr Opin Organ Transplant. 2024; 29(2):131-137.
PMID: 38288947 PMC: 10919264. DOI: 10.1097/MOT.0000000000001139.